Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness.


Journal

Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592

Informations de publication

Date de publication:
02 2023
Historique:
received: 08 02 2022
accepted: 19 12 2022
pubmed: 31 1 2023
medline: 3 3 2023
entrez: 30 1 2023
Statut: ppublish

Résumé

The accumulation of acidic metabolic waste products within the tumor microenvironment inhibits effector functions of tumor-infiltrating lymphocytes (TILs). However, it remains unclear how an acidic environment affects T cell metabolism and differentiation. Here we show that prolonged exposure to acid reprograms T cell intracellular metabolism and mitochondrial fitness and preserves T cell stemness. Mechanistically, elevated extracellular acidosis impairs methionine uptake and metabolism via downregulation of SLC7A5, therefore altering H3K27me3 deposition at the promoters of key T cell stemness genes. These changes promote the maintenance of a 'stem-like memory' state and improve long-term in vivo persistence and anti-tumor efficacy in mice. Our findings not only reveal an unexpected capacity of extracellular acidosis to maintain the stem-like properties of T cells, but also advance our understanding of how methionine metabolism affects T cell stemness.

Identifiants

pubmed: 36717749
doi: 10.1038/s42255-022-00730-6
pii: 10.1038/s42255-022-00730-6
pmc: PMC9970874
doi:

Substances chimiques

Carbon 7440-44-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

314-330

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s).

Références

Gattinoni, L., Speiser, D. E., Lichterfeld, M. & Bonini, C. T memory stem cells in health and disease. Nat. Med. 23, 18–27 (2017).
pubmed: 28060797 pmcid: 6354775 doi: 10.1038/nm.4241
Gao, S. et al. Stem cell-like memory T cells: a perspective from the dark side. Cell Immunol. 361, 104273 (2021).
pubmed: 33422699 doi: 10.1016/j.cellimm.2020.104273
Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015).
pubmed: 25838374 pmcid: 6295668 doi: 10.1126/science.aaa4967
Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350–1355 (2018).
pubmed: 29567705 pmcid: 7391259 doi: 10.1126/science.aar4060
Lugli, E., Galletti, G., Boi, S. K. & Youngblood, B. A. Stem, effector, and hybrid states of memory CD8
pubmed: 31810790 doi: 10.1016/j.it.2019.11.004
Galletti, G. et al. Two subsets of stem-like CD8
pubmed: 33046887 pmcid: 7610790 doi: 10.1038/s41590-020-0791-5
Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290–1297 (2011).
pubmed: 21926977 pmcid: 3192229 doi: 10.1038/nm.2446
Franco, F., Jaccard, A., Romero, P., Yu, Y. R. & Ho, P. C. Metabolic and epigenetic regulation of T-cell exhaustion. Nat. Metab. 2, 1001–1012 (2020).
pubmed: 32958939 doi: 10.1038/s42255-020-00280-9
Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8
pubmed: 23080391 pmcid: 4137483 doi: 10.1038/nri3307
Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8
pubmed: 36208623 doi: 10.1016/j.cell.2022.09.020
Siddiqui, I. et al. Intratumoral Tcf1
pubmed: 30635237 doi: 10.1016/j.immuni.2018.12.021
Jeannet, G. et al. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc. Natl Acad. Sci. USA 107, 9777–9782 (2010).
pubmed: 20457902 pmcid: 2906901 doi: 10.1073/pnas.0914127107
Henning, A. N., Roychoudhuri, R. & Restifo, N. P. Epigenetic control of CD8
pubmed: 29379213 pmcid: 6327307 doi: 10.1038/nri.2017.146
Crompton, J. G. et al. Lineage relationship of CD8
pubmed: 25914936 doi: 10.1038/cmi.2015.32
Yu, B. et al. Epigenetic landscapes reveal transcription factors that regulate CD8
pubmed: 28288100 pmcid: 5395420 doi: 10.1038/ni.3706
Araki, Y. et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8
pubmed: 19523850 pmcid: 2709841 doi: 10.1016/j.immuni.2009.05.006
Moller, S. H., Hsueh, P. C., Yu, Y. R., Zhang, L. & Ho, P. C. Metabolic programs tailor T cell immunity in viral infection, cancer, and aging. Cell Metab. 34, 378–395 (2022).
pubmed: 35235773 doi: 10.1016/j.cmet.2022.02.003
Phan, A. T. et al. Constitutive glycolytic metabolism supports CD8
pubmed: 27836431 pmcid: 5130099 doi: 10.1016/j.immuni.2016.10.017
Sinclair, L. V. et al. Antigen receptor control of methionine metabolism in T cells. eLife 8, e44210 (2019).
pubmed: 30916644 pmcid: 6497464 doi: 10.7554/eLife.44210
O’Sullivan, D. et al. Memory CD8
pubmed: 25001241 pmcid: 4120664 doi: 10.1016/j.immuni.2014.06.005
Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103–107 (2009).
pubmed: 19494812 pmcid: 2803086 doi: 10.1038/nature08097
Van der Windt, G. J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8
pubmed: 22206904 doi: 10.1016/j.immuni.2011.12.007
Boedtkjer, E. & Pedersen, S. F. The acidic tumor microenvironment as a driver of cancer. Annu. Rev. Physiol. 82, 103–126 (2020).
pubmed: 31730395 doi: 10.1146/annurev-physiol-021119-034627
Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547–562 (2018).
pubmed: 29634943 pmcid: 7116508 doi: 10.1016/j.ccell.2018.03.012
Scharping, N. E. et al. The tumor microenvironment represses t cell mitochondrial biogenesis to drive intratumoral t cell metabolic insufficiency and dysfunction. Immunity 45, 374–388 (2016).
pubmed: 27496732 pmcid: 5207350 doi: 10.1016/j.immuni.2016.07.009
Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8
pubmed: 33020660 doi: 10.1038/s41590-020-0793-3
Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229–1241 (2015).
pubmed: 26321679 pmcid: 4864363 doi: 10.1016/j.cell.2015.08.016
Scharping, N. E. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat. Immunol. 22, 205–215 (2021).
pubmed: 33398183 pmcid: 7971090 doi: 10.1038/s41590-020-00834-9
Jansen, C. S. et al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature 576, 465–470 (2019).
pubmed: 31827286 pmcid: 7108171 doi: 10.1038/s41586-019-1836-5
Im, S. J. et al. Defining CD8
pubmed: 27501248 pmcid: 5297183 doi: 10.1038/nature19330
Haas, R. et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 13, e1002202 (2015).
pubmed: 26181372 pmcid: 4504715 doi: 10.1371/journal.pbio.1002202
Wu, H. et al. T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nat. Commun. 11, 4113 (2020).
pubmed: 32807791 pmcid: 7431837 doi: 10.1038/s41467-020-17756-7
Calcinotto, A. et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 72, 2746–2756 (2012).
pubmed: 22593198 doi: 10.1158/0008-5472.CAN-11-1272
Gottfried, E. et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107, 2013–2021 (2006).
pubmed: 16278308 doi: 10.1182/blood-2005-05-1795
Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).
pubmed: 25043024 pmcid: 4301845 doi: 10.1038/nature13490
Erra Diaz, F. et al. Extracellular acidosis and mTOR inhibition drive the differentiation of human monocyte-derived dendritic cells. Cell Rep. 31, 107613 (2020).
pubmed: 32375041 doi: 10.1016/j.celrep.2020.107613
Sukumar, M. et al. Inhibiting glycolytic metabolism enhances CD8
pubmed: 24091329 pmcid: 3784544 doi: 10.1172/JCI69589
Scholz, G. et al. Modulation of mTOR signalling triggers the formation of stem cell-like memory T cells. EBioMedicine 4, 50–61 (2016).
pubmed: 26981571 pmcid: 4776068 doi: 10.1016/j.ebiom.2016.01.019
Pollizzi, K. N. et al. mTORC1 and mTORC2 selectively regulate CD8
pubmed: 25893604 pmcid: 4463194 doi: 10.1172/JCI77746
Zhang, L. et al. Mammalian target of rapamycin complex 2 controls CD8 T cell memory differentiation in a Foxo1-dependent manner. Cell Rep. 14, 1206–1217 (2016).
pubmed: 26804903 doi: 10.1016/j.celrep.2015.12.095
Zhou, H. & Huang, S. Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr. Protein Pept. Sci. 12, 30–42 (2011).
pubmed: 21190521 pmcid: 3410744 doi: 10.2174/138920311795659407
Arguello, R. J. et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, 1063–1075 (2020).
pubmed: 33264598 pmcid: 8407169 doi: 10.1016/j.cmet.2020.11.007
Ron-Harel, N. et al. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab. 24, 104–117 (2016).
pubmed: 27411012 pmcid: 5330619 doi: 10.1016/j.cmet.2016.06.007
Han, C., Ge, M., Ho, P. C. & Zhang, L. Fueling T-cell antitumor immunity: amino acid metabolism revisited. Cancer Immunol. Res. 9, 1373–1382 (2021).
pubmed: 34716193 doi: 10.1158/2326-6066.CIR-21-0459
Kakaradov, B. et al. Early transcriptional and epigenetic regulation of CD8
pubmed: 28218746 pmcid: 5360497 doi: 10.1038/ni.3688
Wang, W. & Zou, W. Amino acids and their transporters in T cell immunity and cancer therapy. Mol. Cell 80, 384–395 (2020).
pubmed: 32997964 pmcid: 7655528 doi: 10.1016/j.molcel.2020.09.006
Marchingo, J. M., Sinclair, L. V., Howden, A. J. & Cantrell, D. A. Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation. eLife 9, e53725 (2020).
Sukumar, M. et al. Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy. Cell Metab. 23, 63–76 (2016).
pubmed: 26674251 doi: 10.1016/j.cmet.2015.11.002
Alizadeh, D. et al. IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype. Cancer Immunol. Res. 7, 759–772 (2019).
pubmed: 30890531 pmcid: 6687561 doi: 10.1158/2326-6066.CIR-18-0466
Buck, M. D. et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166, 63–76 (2016).
pubmed: 27293185 pmcid: 4974356 doi: 10.1016/j.cell.2016.05.035
Krishna, S. et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science 370, 1328–1334 (2020).
pubmed: 33303615 pmcid: 8883579 doi: 10.1126/science.abb9847
Burger, M. L. et al. Antigen dominance hierarchies shape TCF1
pubmed: 34534464 pmcid: 8522630 doi: 10.1016/j.cell.2021.08.020
Guo, Y. et al. Metabolic reprogramming of terminally exhausted CD8
pubmed: 34031618 pmcid: 7610876 doi: 10.1038/s41590-021-00940-2
Klein Geltink, R. I. et al. Metabolic conditioning of CD8
pubmed: 32747793 doi: 10.1038/s42255-020-0256-z
Suzuki, J., Nabe, S., Yasukawa, M. & Yamashita, M. Glutamine regulates the antitumor activity of CD8 T cells. Gan To Kagaku Ryoho 47, 11–15 (2020).
pubmed: 32381854
Vodnala, S. K. et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 363, eaau0135 (2019).
pubmed: 30923193 pmcid: 8194369 doi: 10.1126/science.aau0135
Bosticardo, M. et al. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation. Eur. J. Immunol. 31, 2829–2838 (2001).
pubmed: 11536182 doi: 10.1002/1521-4141(200109)31:9<2829::AID-IMMU2829>3.0.CO;2-U
Pucino, V. et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4
pubmed: 31708446 pmcid: 6899510 doi: 10.1016/j.cmet.2019.10.004
Feng, Q. et al. Lactate increases stemness of CD8
pubmed: 36068198 pmcid: 9448806 doi: 10.1038/s41467-022-32521-8
Roy, D. G. et al. Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming. Cell Metab. 31, 250–266 (2020).
pubmed: 32023446 doi: 10.1016/j.cmet.2020.01.006
Zhang, L. & Romero, P. Metabolic control of CD8
pubmed: 29246759 doi: 10.1016/j.molmed.2017.11.005
Cham, C. M., Driessens, G., O’Keefe, J. P. & Gajewski, T. F. Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8
pubmed: 18792400 pmcid: 3008428 doi: 10.1002/eji.200838289
O’Sullivan, D. et al. Memory CD8
pubmed: 30134202 pmcid: 6167519 doi: 10.1016/j.immuni.2018.07.018
Lin, R. et al. Fatty acid oxidation controls CD8
pubmed: 32075801 doi: 10.1158/2326-6066.CIR-19-0702
Raud, B. et al. Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation. Cell Metab. 28, 504–515 (2018).
pubmed: 30043753 pmcid: 6747686 doi: 10.1016/j.cmet.2018.06.002
Sharma, U. & Rando, O. J. Metabolic inputs into the epigenome. Cell Metab. 25, 544–558 (2017).
pubmed: 28273477 doi: 10.1016/j.cmet.2017.02.003
Tyrakis, P. A. et al. S-2-hydroxyglutarate regulates CD8
pubmed: 27798602 pmcid: 5149074 doi: 10.1038/nature20165
Zhang, H. et al. Ketogenesis-generated beta-hydroxybutyrate is an epigenetic regulator of CD8
pubmed: 31871320 doi: 10.1038/s41556-019-0440-0
Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585, 277–282 (2020).
pubmed: 32879489 pmcid: 7486248 doi: 10.1038/s41586-020-2682-1
Wall, M. et al. Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation. Blood 112, 2305–2317 (2008).
pubmed: 18621930 doi: 10.1182/blood-2007-09-111856
Yerinde, C., Siegmund, B., Glauben, R. & Weidinger, C. Metabolic control of epigenetics and its role in CD8
pubmed: 31849941 pmcid: 6901948 doi: 10.3389/fimmu.2019.02718
Eil, R. et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature 537, 539–543 (2016).
pubmed: 27626381 pmcid: 5204372 doi: 10.1038/nature19364
Guo, A. et al. cBAF complex components and MYC cooperate early in CD8
pubmed: 35732731 pmcid: 9623036 doi: 10.1038/s41586-022-04849-0
Raynor, J. L., Chapman, N. M. & Chi, H. Metabolic control of memory T-cell generation and stemness. Cold Spring Harb. Perspect. Biol. 13, a037770 (2021).
pubmed: 33820774 doi: 10.1101/cshperspect.a037770
Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).
pubmed: 31036827 pmcid: 6488672 doi: 10.1038/s41467-019-09982-5
Jin, H. et al. ChIPseqSpikeInFree: a ChIP–seq normalization approach to reveal global changes in histone modifications without spike-in. Bioinformatics 36, 1270–1272 (2020).
pubmed: 31566663 doi: 10.1093/bioinformatics/btz720
Sellick, C. A., Hansen, R., Stephens, G. M., Goodacre, R. & Dickson, A. J. Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling. Nat. Protoc. 6, 1241–1249 (2011).
pubmed: 21799492 doi: 10.1038/nprot.2011.366
Li, C. et al. Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2–eIF2α axis. Cell Stem Cell 29, 1119–1134 (2022).
pubmed: 35803229 doi: 10.1016/j.stem.2022.06.004
Wenes, M. et al. The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function. Cell Metab. 34, 731–746 (2022).
pubmed: 35452600 pmcid: 9116152 doi: 10.1016/j.cmet.2022.03.013

Auteurs

Hongcheng Cheng (H)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Yajing Qiu (Y)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Yue Xu (Y)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Li Chen (L)

Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China.

Kaili Ma (K)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Mengyuan Tao (M)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.
School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Luke Frankiw (L)

Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Hongli Yin (H)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Ermei Xie (E)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.
Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing, China.

Xiaoli Pan (X)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Jing Du (J)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Zhe Wang (Z)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Wenjie Zhu (W)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Suzhou Institute of Systems Medicine, Suzhou, China.

Lu Chen (L)

Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China. luchen@scu.edu.cn.

Lianjun Zhang (L)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. zlj@ism.cams.cn.
Suzhou Institute of Systems Medicine, Suzhou, China. zlj@ism.cams.cn.
Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China. zlj@ism.cams.cn.

Guideng Li (G)

Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. lgd@ism.cams.cn.
Suzhou Institute of Systems Medicine, Suzhou, China. lgd@ism.cams.cn.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH